Treating hypercholesterinemia in a patient with maternally inherited diabetes and deafness (MIDD) by the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor alirocumab

被引：0
|
作者：
Schultes, Bernd [1 ,2 ]
Ernst, Barbara [1 ]
Schmid, Sebastian M. [2 ,3 ]
机构：
[1] FriendlyDocs Ltd, Metab Ctr St Gallen, Lerchentalst 21, CH-9016 St Gallen, Switzerland
[2] Univ Lubeck, Inst Endocrinol & Diabet, Lubeck, Germany
[3] German Ctr Diabet Res, Neuherberg, Germany
来源：
ACTA DIABETOLOGICA | 2021年 / 58卷 / 11期
关键词：
MIDD; PCSK9; inhibitors; Hypercholesterinemia; Arteriosclerotic cardiovascular disease; Mitochondrial;
D O I：
10.1007/s00592-021-01776-w
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1575 / 1577
页数：3
相关论文
共 50 条
  • [1] Treating hypercholesterinemia in a patient with maternally inherited diabetes and deafness (MIDD) by the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor alirocumab
    Bernd Schultes
    Barbara Ernst
    Sebastian M. Schmid
    Acta Diabetologica, 2021, 58 : 1575 - 1577
  • [2] Proprotein convertase subtilisin/kexin type 9 (PCSK9) and inhibitors
    Avci, Ahmet
    Demir, Kenan
    Altunkeser, Bulent Behlul
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2014, 42 : 56 - 67
  • [3] Effects of a Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) Inhibitor, Alirocumab, on Lipid and Lipoprotein Metabolism in Healthy Subjects
    Reyes-Soffer, Gissette
    Pavlyha, Marianna
    Ngai, Colleen
    Thomas, Tiffany
    Holleran, Stephen
    Ramakrishnan, Sekhar
    Karmally, Wahida
    Donovan, Daniel
    Cowan, Lisa
    Sasiela, William
    Surks, Howard
    Rey, Jacques
    Poitiers, Frank
    Ginsberg, Henry
    CIRCULATION, 2015, 132
  • [4] Proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors
    Leong, Derek
    Wu, Peter E.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2019, 191 (32) : E894 - E894
  • [5] PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9): A Narrative Review
    Dua, Pamila
    Reeta, K. H.
    JOURNAL OF THE PRACTICE OF CARDIOVASCULAR SCIENCES, 2020, 6 (03) : 226 - 233
  • [6] Regulation of ENaC by proprotein convertase subtilisin/kexin type 9(PCSK9)
    Sharotri, Vikas
    Snyder, Peter M.
    FASEB JOURNAL, 2010, 24
  • [7] PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Goes "DAMP"
    Silverstein, Roy L.
    CIRCULATION, 2021, 143 (01) : 62 - 64
  • [8] Role of proprotein convertase subtilisin/kexin type 9 (PCSK9) in diabetic complications
    Imaralu, Omonzejie E.
    Narasimhulu, Chandrakala Aluganti
    Singal, Pawan K.
    Singla, Dinender K.
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2024, 102 (01) : 14 - 25
  • [9] Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9)
    Rainer Schulz
    Klaus-Dieter Schlüter
    Ulrich Laufs
    Basic Research in Cardiology, 2015, 110
  • [10] Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9)
    Schulz, Rainer
    Schlueter, Klaus-Dieter
    Laufs, Ulrich
    BASIC RESEARCH IN CARDIOLOGY, 2015, 110 (02)
12345